Table of Content

1 Report Overview
1.1 Antiemetics Definition
1.2 Market by Type
1.2.1 Global Antiemetics Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 5-HT3 receptor antagonists
1.2.3 Dopamine antagonists
1.2.4 NK1 receptor antagonist
1.2.5 Antihistamines (H1 histamine receptor antagonists)
1.2.6 Cannabinoids
1.2.7 Benzodiazepines
1.2.8 Anticholinergics
1.2.9 Steroids
1.2.10 Others
1.3 Market Segment by Application
1.3.1 Global Antiemetics Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Antiemetics Sales
2.1 Global Antiemetics Revenue Estimates and Forecasts 2018-2034
2.2 Global Antiemetics Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Antiemetics Revenue by Region
2.3.1 Global Antiemetics Revenue by Region (2018-2023)
2.3.2 Global Antiemetics Revenue by Region (2024-2034)
2.4 Global Antiemetics Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Antiemetics Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Antiemetics Sales Quantity by Region
2.6.1 Global Antiemetics Sales Quantity by Region (2018-2023)
2.6.2 Global Antiemetics Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Antiemetics Sales Quantity by Manufacturers
3.1.1 Global Antiemetics Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Antiemetics Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Antiemetics Sales in 2024
3.2 Global Antiemetics Revenue by Manufacturers
3.2.1 Global Antiemetics Revenue by Manufacturers (2018-2023)
3.2.2 Global Antiemetics Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Antiemetics Revenue in 2024
3.3 Global Antiemetics Sales Price by Manufacturers
3.4 Global Key Players of Antiemetics, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antiemetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antiemetics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antiemetics, Product Offered and Application
3.8 Global Key Manufacturers of Antiemetics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Antiemetics Sales Quantity by Type
4.1.1 Global Antiemetics Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Antiemetics Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Antiemetics Sales Quantity Market Share by Type (2018-2034)
4.2 Global Antiemetics Revenue by Type
4.2.1 Global Antiemetics Historical Revenue by Type (2018-2023)
4.2.2 Global Antiemetics Forecasted Revenue by Type (2024-2034)
4.2.3 Global Antiemetics Revenue Market Share by Type (2018-2034)
4.3 Global Antiemetics Price by Type
4.3.1 Global Antiemetics Price by Type (2018-2023)
4.3.2 Global Antiemetics Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Antiemetics Sales Quantity by Application
5.1.1 Global Antiemetics Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Antiemetics Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Antiemetics Sales Quantity Market Share by Application (2018-2034)
5.2 Global Antiemetics Revenue by Application
5.2.1 Global Antiemetics Historical Revenue by Application (2018-2023)
5.2.2 Global Antiemetics Forecasted Revenue by Application (2024-2034)
5.2.3 Global Antiemetics Revenue Market Share by Application (2018-2034)
5.3 Global Antiemetics Price by Application
5.3.1 Global Antiemetics Price by Application (2018-2023)
5.3.2 Global Antiemetics Price Forecast by Application (2024-2034)
6 North America
6.1 North America Antiemetics Sales by Company
6.1.1 North America Antiemetics Revenue by Company (2018-2023)
6.1.2 North America Antiemetics Sales Quantity by Company (2018-2023)
6.2 North America Antiemetics Market Size by Type
6.2.1 North America Antiemetics Sales Quantity by Type (2018-2034)
6.2.2 North America Antiemetics Revenue by Type (2018-2034)
6.3 North America Antiemetics Market Size by Application
6.3.1 North America Antiemetics Sales Quantity by Application (2018-2034)
6.3.2 North America Antiemetics Revenue by Application (2018-2034)
6.4 North America Antiemetics Market Size by Country
6.4.1 North America Antiemetics Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Antiemetics Revenue by Country (2018-2034)
6.4.3 North America Antiemetics Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Antiemetics Sales by Company
7.1.1 Europe Antiemetics Sales Quantity by Company (2018-2023)
7.1.2 Europe Antiemetics Revenue by Company (2018-2023)
7.2 Europe Antiemetics Market Size by Type
7.2.1 Europe Antiemetics Sales Quantity by Type (2018-2034)
7.2.2 Europe Antiemetics Revenue by Type (2018-2034)
7.3 Europe Antiemetics Market Size by Application
7.3.1 Europe Antiemetics Sales Quantity by Application (2018-2034)
7.3.2 Europe Antiemetics Revenue by Application (2018-2034)
7.4 Europe Antiemetics Market Size by Country
7.4.1 Europe Antiemetics Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Antiemetics Revenue by Country (2018-2034)
7.4.3 Europe Antiemetics Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Antiemetics Sales by Company
8.1.1 China Antiemetics Sales Quantity by Company (2018-2023)
8.1.2 China Antiemetics Revenue by Company (2018-2023)
8.2 China Antiemetics Market Size by Type
8.2.1 China Antiemetics Sales Quantity by Type (2018-2034)
8.2.2 China Antiemetics Revenue by Type (2018-2034)
8.3 China Antiemetics Market Size by Application
8.3.1 China Antiemetics Sales Quantity by Application (2018-2034)
8.3.2 China Antiemetics Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Antiemetics Sales by Company
9.1.1 APAC Antiemetics Sales Quantity by Company (2018-2023)
9.1.2 APAC Antiemetics Revenue by Company (2018-2023)
9.2 APAC Antiemetics Market Size by Type
9.2.1 APAC Antiemetics Sales Quantity by Type (2018-2034)
9.2.2 APAC Antiemetics Revenue by Type (2018-2034)
9.3 APAC Antiemetics Market Size by Application
9.3.1 APAC Antiemetics Sales Quantity by Application (2018-2034)
9.3.2 APAC Antiemetics Revenue by Application (2018-2034)
9.4 APAC Antiemetics Market Size by Region
9.4.1 APAC Antiemetics Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Antiemetics Revenue by Region (2018-2034)
9.4.3 APAC Antiemetics Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antiemetics Sales by Company
10.1.1 Middle East, Africa and Latin America Antiemetics Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Antiemetics Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Antiemetics Market Size by Type
10.2.1 Middle East, Africa and Latin America Antiemetics Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Antiemetics Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Antiemetics Market Size by Application
10.3.1 Middle East, Africa and Latin America Antiemetics Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Antiemetics Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Antiemetics Market Size by Country
10.4.1 Middle East, Africa and Latin America Antiemetics Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Antiemetics Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Antiemetics Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 GlaxoSmithKline Antiemetics Products and Services
11.1.5 GlaxoSmithKline Antiemetics SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Merck Antiemetics Products and Services
11.2.5 Merck Antiemetics SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Information
11.3.2 Sanofi Aventis Overview
11.3.3 Sanofi Aventis Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Sanofi Aventis Antiemetics Products and Services
11.3.5 Sanofi Aventis Antiemetics SWOT Analysis
11.3.6 Sanofi Aventis Recent Developments
11.4 Bristol Myers Squibb
11.4.1 Bristol Myers Squibb Company Information
11.4.2 Bristol Myers Squibb Overview
11.4.3 Bristol Myers Squibb Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Bristol Myers Squibb Antiemetics Products and Services
11.4.5 Bristol Myers Squibb Antiemetics SWOT Analysis
11.4.6 Bristol Myers Squibb Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Eli Lilly Antiemetics Products and Services
11.5.5 Eli Lilly Antiemetics SWOT Analysis
11.5.6 Eli Lilly Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Pfizer Antiemetics Products and Services
11.6.5 Pfizer Antiemetics SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Astellas
11.7.1 Astellas Company Information
11.7.2 Astellas Overview
11.7.3 Astellas Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Astellas Antiemetics Products and Services
11.7.5 Astellas Antiemetics SWOT Analysis
11.7.6 Astellas Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Johnson & Johnson Antiemetics Products and Services
11.8.5 Johnson & Johnson Antiemetics SWOT Analysis
11.8.6 Johnson & Johnson Recent Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Overview
11.9.3 Baxter Antiemetics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Baxter Antiemetics Products and Services
11.9.5 Baxter Antiemetics SWOT Analysis
11.9.6 Baxter Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antiemetics Value Chain Analysis
12.2 Antiemetics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiemetics Production Mode & Process
12.4 Antiemetics Sales and Marketing
12.4.1 Antiemetics Sales Channels
12.4.2 Antiemetics Distributors
12.5 Antiemetics Customers
13 Market Dynamics
13.1 Antiemetics Industry Trends
13.2 Antiemetics Market Drivers
13.3 Antiemetics Market Challenges
13.4 Antiemetics Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antiemetics Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 5-HT3 receptor antagonists
Table 3. Major Manufacturers of Dopamine antagonists
Table 4. Major Manufacturers of NK1 receptor antagonist
Table 5. Major Manufacturers of Antihistamines (H1 histamine receptor antagonists)
Table 6. Major Manufacturers of Cannabinoids
Table 7. Major Manufacturers of Benzodiazepines
Table 8. Major Manufacturers of Anticholinergics
Table 9. Major Manufacturers of Steroids
Table 10. Major Manufacturers of Others
Table 11. Global Antiemetics Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 12. Global Antiemetics Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 13. Global Antiemetics Revenue by Region (2018-2023) & (US$ Million)
Table 14. Global Antiemetics Revenue Market Share by Region (2018-2023)
Table 15. Global Antiemetics Revenue by Region (2024-2034) & (US$ Million)
Table 16. Global Antiemetics Revenue Market Share by Region (2024-2034)
Table 17. Global Antiemetics Sales Quantity by Region: 2018 VS 2024 VS 2034 (Units)
Table 18. Global Antiemetics Sales by Region (2018-2023) & (Units)
Table 19. Global Antiemetics Sales Market Share by Region (2018-2023)
Table 20. Global Antiemetics Sales by Region (2024-2034) & (Units)
Table 21. Global Antiemetics Sales Market Share by Region (2024-2034)
Table 22. Global Antiemetics Sales Quantity by Manufacturers (2018-2023) & (Units)
Table 23. Global Antiemetics Sales Quantity Share by Manufacturers (2018-2023)
Table 24. Global Antiemetics Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 25. Global Antiemetics Revenue Share by Manufacturers (2018-2023)
Table 26. Global Antiemetics Price by Manufacturers 2018-2023 (USD/Unit)
Table 27. Global Key Players of Antiemetics, Industry Ranking, 2021 VS 2024
Table 28. Global Antiemetics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Antiemetics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiemetics as of 2024)
Table 30. Global Key Manufacturers of Antiemetics, Manufacturing Base Distribution and Headquarters
Table 31. Global Key Manufacturers of Antiemetics, Product Offered and Application
Table 32. Global Key Manufacturers of Antiemetics, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Antiemetics Sales Quantity by Type (2018-2023) & (Units)
Table 35. Global Antiemetics Sales Quantity by Type (2024-2034) & (Units)
Table 36. Global Antiemetics Sales Quantity Share by Type (2018-2023)
Table 37. Global Antiemetics Sales Quantity Share by Type (2024-2034)
Table 38. Global Antiemetics Revenue by Type (2018-2023) & (US$ Million)
Table 39. Global Antiemetics Revenue by Type (2024-2034) & (US$ Million)
Table 40. Global Antiemetics Revenue Share by Type (2018-2023)
Table 41. Global Antiemetics Revenue Share by Type (2024-2034)
Table 42. Antiemetics Price by Type (2018-2023) & (USD/Unit)
Table 43. Global Antiemetics Price Forecast by Type (2024-2034) & (USD/Unit)
Table 44. Global Antiemetics Sales Quantity by Application (2018-2023) & (Units)
Table 45. Global Antiemetics Sales Quantity by Application (2024-2034) & (Units)
Table 46. Global Antiemetics Sales Quantity Share by Application (2018-2023)
Table 47. Global Antiemetics Sales Quantity Share by Application (2024-2034)
Table 48. Global Antiemetics Revenue by Application (2018-2023) & (US$ Million)
Table 49. Global Antiemetics Revenue by Application (2024-2034) & (US$ Million)
Table 50. Global Antiemetics Revenue Share by Application (2018-2023)
Table 51. Global Antiemetics Revenue Share by Application (2024-2034)
Table 52. Antiemetics Price by Application (2018-2023) & (USD/Unit)
Table 53. Global Antiemetics Price Forecast by Application (2024-2034) & (USD/Unit)
Table 54. North America Antiemetics Revenue by Company (2018-2023) & (US$ Million)
Table 55. North America Antiemetics Sales Quantity by Company (2018-2023) & (Units)
Table 56. North America Antiemetics Sales Quantity by Type (2018-2023) & (Units)
Table 57. North America Antiemetics Sales Quantity by Type (2024-2034) & (Units)
Table 58. North America Antiemetics Revenue by Type (2018-2023) & (US$ Million)
Table 59. North America Antiemetics Revenue by Type (2024-2034) & (US$ Million)
Table 60. North America Antiemetics Sales Quantity by Application (2018-2023) & (Units)
Table 61. North America Antiemetics Sales Quantity by Application (2024-2034) & (Units)
Table 62. North America Antiemetics Revenue by Application (2018-2023) & (US$ Million)
Table 63. North America Antiemetics Revenue by Application (2024-2034) & (US$ Million)
Table 64. North America Antiemetics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 65. North America Antiemetics Revenue by Country (2018-2023) & (US$ Million)
Table 66. North America Antiemetics Revenue by Country (2024-2034) & (US$ Million)
Table 67. North America Antiemetics Sales Quantity by Country (2018-2023) & (Units)
Table 68. North America Antiemetics Sales Quantity by Country (2024-2034) & (Units)
Table 69. Europe Antiemetics Sales Quantity by Company (2018-2023) & (Units)
Table 70. Europe Antiemetics Revenue by Company (2018-2023) & (US$ Million)
Table 71. Europe Antiemetics Sales Quantity by Type (2018-2023) & (Units)
Table 72. Europe Antiemetics Sales Quantity by Type (2024-2034) & (Units)
Table 73. Europe Antiemetics Revenue by Type (2018-2023) & (US$ Million)
Table 74. Europe Antiemetics Revenue by Type (2024-2034) & (US$ Million)
Table 75. Europe Antiemetics Sales Quantity by Application (2018-2023) & (Units)
Table 76. Europe Antiemetics Sales Quantity by Application (2024-2034) & (Units)
Table 77. Europe Antiemetics Revenue by Application (2018-2023) & (US$ Million)
Table 78. Europe Antiemetics Revenue by Application (2024-2034) & (US$ Million)
Table 79. Europe Antiemetics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 80. Europe Antiemetics Revenue by Country (2018-2023) & (US$ Million)
Table 81. Europe Antiemetics Revenue by Country (2024-2034) & (US$ Million)
Table 82. Europe Antiemetics Sales Quantity by Country (2018-2023) & (Units)
Table 83. Europe Antiemetics Sales Quantity by Country (2024-2034) & (Units)
Table 84. China Antiemetics Sales Quantity by Company (2018-2023) & (Units)
Table 85. China Antiemetics Revenue by Company (2018-2023) & (US$ Million)
Table 86. China Antiemetics Sales Quantity by Type (2018-2023) & (Units)
Table 87. China Antiemetics Sales Quantity by Type (2024-2034) & (Units)
Table 88. China Antiemetics Revenue by Type (2018-2023) & (US$ Million)
Table 89. China Antiemetics Revenue by Type (2024-2034) & (US$ Million)
Table 90. China Antiemetics Sales Quantity by Application (2018-2023) & (Units)
Table 91. China Antiemetics Sales Quantity by Application (2024-2034) & (Units)
Table 92. China Antiemetics Revenue by Application (2018-2023) & (US$ Million)
Table 93. China Antiemetics Revenue by Application (2024-2034) & (US$ Million)
Table 94. APAC Antiemetics Sales Quantity by Company (2018-2023) & (Units)
Table 95. APAC Antiemetics Revenue by Company (2018-2023) & (US$ Million)
Table 96. APAC Antiemetics Sales Quantity by Type (2018-2023) & (Units)
Table 97. APAC Antiemetics Sales Quantity by Type (2024-2034) & (Units)
Table 98. APAC Antiemetics Revenue by Type (2018-2023) & (US$ Million)
Table 99. APAC Antiemetics Revenue by Type (2024-2034) & (US$ Million)
Table 100. APAC Antiemetics Sales Quantity by Application (2018-2023) & (Units)
Table 101. APAC Antiemetics Sales Quantity by Application (2024-2034) & (Units)
Table 102. APAC Antiemetics Revenue by Application (2018-2023) & (US$ Million)
Table 103. APAC Antiemetics Revenue by Application (2024-2034) & (US$ Million)
Table 104. APAC Antiemetics Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 105. APAC Antiemetics Revenue by Region (2018-2023) & (US$ Million)
Table 106. APAC Antiemetics Revenue by Region (2024-2034) & (US$ Million)
Table 107. APAC Antiemetics Sales Quantity by Region (2018-2023) & (Units)
Table 108. APAC Antiemetics Sales Quantity by Region (2024-2034) & (Units)
Table 109. Middle East, Africa and Latin America Antiemetics Sales Quantity by Company (2018-2023) & (Units)
Table 110. Middle East, Africa and Latin America Antiemetics Revenue by Company (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Antiemetics Sales Quantity by Type (2018-2023) & (Units)
Table 112. Middle East, Africa and Latin America Antiemetics Sales Quantity by Type (2024-2034) & (Units)
Table 113. Middle East, Africa and Latin America Antiemetics Revenue by Type (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Antiemetics Revenue by Type (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Antiemetics Sales Quantity by Application (2018-2023) & (Units)
Table 116. Middle East, Africa and Latin America Antiemetics Sales Quantity by Application (2024-2034) & (Units)
Table 117. Middle East, Africa and Latin America Antiemetics Revenue by Application (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America Antiemetics Revenue by Application (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Antiemetics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 120. Middle East, Africa and Latin America Antiemetics Revenue by Country (2018-2023) & (US$ Million)
Table 121. Middle East, Africa and Latin America Antiemetics Revenue by Country (2024-2034) & (US$ Million)
Table 122. Middle East, Africa and Latin America Antiemetics Sales Quantity by Country (2018-2023) & (Units)
Table 123. Middle East, Africa and Latin America Antiemetics Sales Quantity by Country (2024-2034) & (Units)
Table 124. GlaxoSmithKline Company Information
Table 125. GlaxoSmithKline Description and Overview
Table 126. GlaxoSmithKline Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 127. GlaxoSmithKline Antiemetics Product and Services
Table 128. GlaxoSmithKline Antiemetics SWOT Analysis
Table 129. GlaxoSmithKline Recent Developments
Table 130. Merck Company Information
Table 131. Merck Description and Overview
Table 132. Merck Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 133. Merck Antiemetics Product and Services
Table 134. Merck Antiemetics SWOT Analysis
Table 135. Merck Recent Developments
Table 136. Sanofi Aventis Company Information
Table 137. Sanofi Aventis Description and Overview
Table 138. Sanofi Aventis Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 139. Sanofi Aventis Antiemetics Product and Services
Table 140. Sanofi Aventis Antiemetics SWOT Analysis
Table 141. Sanofi Aventis Recent Developments
Table 142. Bristol Myers Squibb Company Information
Table 143. Bristol Myers Squibb Description and Overview
Table 144. Bristol Myers Squibb Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 145. Bristol Myers Squibb Antiemetics Product and Services
Table 146. Bristol Myers Squibb Antiemetics SWOT Analysis
Table 147. Bristol Myers Squibb Recent Developments
Table 148. Eli Lilly Company Information
Table 149. Eli Lilly Description and Overview
Table 150. Eli Lilly Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 151. Eli Lilly Antiemetics Product and Services
Table 152. Eli Lilly Antiemetics SWOT Analysis
Table 153. Eli Lilly Recent Developments
Table 154. Pfizer Company Information
Table 155. Pfizer Description and Overview
Table 156. Pfizer Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 157. Pfizer Antiemetics Product and Services
Table 158. Pfizer Antiemetics SWOT Analysis
Table 159. Pfizer Recent Developments
Table 160. Astellas Company Information
Table 161. Astellas Description and Overview
Table 162. Astellas Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 163. Astellas Antiemetics Product and Services
Table 164. Astellas Antiemetics SWOT Analysis
Table 165. Astellas Recent Developments
Table 166. Johnson & Johnson Company Information
Table 167. Johnson & Johnson Description and Overview
Table 168. Johnson & Johnson Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 169. Johnson & Johnson Antiemetics Product and Services
Table 170. Johnson & Johnson Antiemetics SWOT Analysis
Table 171. Johnson & Johnson Recent Developments
Table 172. Baxter Company Information
Table 173. Baxter Description and Overview
Table 174. Baxter Antiemetics Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 175. Baxter Antiemetics Product and Services
Table 176. Baxter Antiemetics SWOT Analysis
Table 177. Baxter Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Antiemetics Distributors List
Table 181. Antiemetics Customers List
Table 182. Antiemetics Market Trends
Table 183. Antiemetics Market Drivers
Table 184. Antiemetics Market Challenges
Table 185. Antiemetics Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiemetics Product Picture
Figure 2. Global Antiemetics Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Antiemetics Market Share by Type in 2024 & 2034
Figure 4. 5-HT3 receptor antagonists Product Picture
Figure 5. Dopamine antagonists Product Picture
Figure 6. NK1 receptor antagonist Product Picture
Figure 7. Antihistamines (H1 histamine receptor antagonists) Product Picture
Figure 8. Cannabinoids Product Picture
Figure 9. Benzodiazepines Product Picture
Figure 10. Anticholinergics Product Picture
Figure 11. Steroids Product Picture
Figure 12. Others Product Picture
Figure 13. Global Antiemetics Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 14. Global Antiemetics Market Share by Application in 2024 & 2034
Figure 15. Hospital Pharmacy
Figure 16. Retail Pharmacy
Figure 17. Online Pharmacy
Figure 18. Others
Figure 19. Antiemetics Report Years Considered
Figure 20. Global Antiemetics Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 21. Global Antiemetics Revenue 2018-2034 (US$ Million)
Figure 22. Global Antiemetics Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 23. Global Antiemetics Sales Quantity 2018-2034 (Units)
Figure 24. Global Antiemetics Sales Quantity Market Share by Region (2018-2023)
Figure 25. Global Antiemetics Sales Quantity Market Share by Region (2024-2034)
Figure 26. North America Antiemetics Sales Quantity YoY (2018-2034) & (Units)
Figure 27. North America Antiemetics Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Europe Antiemetics Sales Quantity YoY (2018-2034) & (Units)
Figure 29. Europe Antiemetics Revenue YoY (2018-2034) & (US$ Million)
Figure 30. China Antiemetics Sales Quantity YoY (2018-2034) & (Units)
Figure 31. China Antiemetics Revenue YoY (2018-2034) & (US$ Million)
Figure 32. APAC Antiemetics Sales Quantity YoY (2018-2034) & (Units)
Figure 33. APAC Antiemetics Revenue YoY (2018-2034) & (US$ Million)
Figure 34. Middle East, Africa and Latin America Antiemetics Sales Quantity YoY (2018-2034) & (Units)
Figure 35. Middle East, Africa and Latin America Antiemetics Revenue YoY (2018-2034) & (US$ Million)
Figure 36. The Top 10 and Top 5 Players Market Share by Antiemetics Sales Quantity in 2024
Figure 37. The Top 10 and Top 5 Players Market Share by Antiemetics Revenue in 2024
Figure 38. Antiemetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 39. Global Antiemetics Sales Quantity Market Share by Type (2018-2034)
Figure 40. Global Antiemetics Revenue Market Share by Type (2018-2034)
Figure 41. Global Antiemetics Sales Quantity Market Share by Application (2018-2034)
Figure 42. Global Antiemetics Revenue Market Share by Application (2018-2034)
Figure 43. North America Antiemetics Revenue Market Share by Company in 2024
Figure 44. North America Antiemetics Sales Quantity Market Share by Company in 2024
Figure 45. North America Antiemetics Sales Quantity Market Share by Type (2018-2034)
Figure 46. North America Antiemetics Revenue Market Share by Type (2018-2034)
Figure 47. North America Antiemetics Sales Quantity Market Share by Application (2018-2034)
Figure 48. North America Antiemetics Revenue Market Share by Application (2018-2034)
Figure 49. North America Antiemetics Revenue Share by Country (2018-2034)
Figure 50. North America Antiemetics Sales Quantity Share by Country (2018-2034)
Figure 51. U.S. Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 52. Canada Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 53. Europe Antiemetics Sales Quantity Market Share by Company in 2024
Figure 54. Europe Antiemetics Revenue Market Share by Company in 2024
Figure 55. Europe Antiemetics Sales Quantity Market Share by Type (2018-2034)
Figure 56. Europe Antiemetics Revenue Market Share by Type (2018-2034)
Figure 57. Europe Antiemetics Sales Quantity Market Share by Application (2018-2034)
Figure 58. Europe Antiemetics Revenue Market Share by Application (2018-2034)
Figure 59. Europe Antiemetics Revenue Share by Country (2018-2034)
Figure 60. Europe Antiemetics Sales Quantity Share by Country (2018-2034)
Figure 61. Germany Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 62. France Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 63. U.K. Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 64. Italy Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 65. Russia Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 66. China Antiemetics Sales Quantity Market Share by Company in 2024
Figure 67. China Antiemetics Revenue Market Share by Company in 2024
Figure 68. China Antiemetics Sales Quantity Market Share by Type (2018-2034)
Figure 69. China Antiemetics Revenue Market Share by Type (2018-2034)
Figure 70. China Antiemetics Sales Quantity Market Share by Application (2018-2034)
Figure 71. China Antiemetics Revenue Market Share by Application (2018-2034)
Figure 72. APAC Antiemetics Sales Quantity Market Share by Company in 2024
Figure 73. APAC Antiemetics Revenue Market Share by Company in 2024
Figure 74. APAC Antiemetics Sales Quantity Market Share by Type (2018-2034)
Figure 75. APAC Antiemetics Revenue Market Share by Type (2018-2034)
Figure 76. APAC Antiemetics Sales Quantity Market Share by Application (2018-2034)
Figure 77. APAC Antiemetics Revenue Market Share by Application (2018-2034)
Figure 78. APAC Antiemetics Revenue Share by Region (2018-2034)
Figure 79. APAC Antiemetics Sales Quantity Share by Region (2018-2034)
Figure 80. Japan Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 81. South Korea Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 82. China Taiwan Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 83. Southeast Asia Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 84. India Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 85. Middle East, Africa and Latin America Antiemetics Sales Quantity Market Share by Company in 2024
Figure 86. Middle East, Africa and Latin America Antiemetics Revenue Market Share by Company in 2024
Figure 87. Middle East, Africa and Latin America Antiemetics Sales Quantity Market Share by Type (2018-2034)
Figure 88. Middle East, Africa and Latin America Antiemetics Revenue Market Share by Type (2018-2034)
Figure 89. Middle East, Africa and Latin America Antiemetics Sales Quantity Market Share by Application (2018-2034)
Figure 90. Middle East, Africa and Latin America Antiemetics Revenue Market Share by Application (2018-2034)
Figure 91. Middle East, Africa and Latin America Antiemetics Sales Quantity Share by Country (2018-2034)
Figure 92. Middle East, Africa and Latin America Antiemetics Revenue Share by Country (2018-2034)
Figure 93. Brazil Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 94. Mexico Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 95. Turkey Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 96. Israel Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 97. GCC Countries Antiemetics Revenue (2018-2034) & (US$ Million)
Figure 98. Antiemetics Value Chain
Figure 99. Antiemetics Production Process
Figure 100. Channels of Distribution (Direct Vs Distribution)
Figure 101. Distributors Profiles
Figure 102. Bottom-up and Top-down Approaches for This Report
Figure 103. Data Triangulation
Figure 104. Key Executives Interviewed